0.03
+0.0058(+27.62%)
Currency In USD
| Previous Close | 0.02 |
| Open | 0.03 |
| Day High | 0.03 |
| Day Low | 0.03 |
| 52-Week High | 0.06 |
| 52-Week Low | 0.02 |
| Volume | 242 |
| Average Volume | 122,561 |
| Market Cap | 2.02M |
| PE | -0.27 |
| EPS | -0.1 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.02 |
| Change | 0.01 |
If you invested $1000 in Galera Therapeutics, Inc. (GRTX) since IPO date, it would be worth $2.23 as of December 25, 2025 at a share price of $0.027. Whereas If you bought $1000 worth of Galera Therapeutics, Inc. (GRTX) shares 5 years ago, it would be worth $2.56 as of December 25, 2025 at a share price of $0.027.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
GlobeNewswire Inc.
Oct 22, 2025 11:00 AM GMT
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 mill
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
GlobeNewswire Inc.
Dec 31, 2024 12:00 PM GMT
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program is Phase 1/2 trial of Nova Pharmaceutical’s Clinical Stage N